TODDE, SERGIO CAMILLO

TODDE, SERGIO CAMILLO  

Mostra records
Risultati 1 - 20 di 31 (tempo di esecuzione: 0.046 secondi).
Titolo Data di pubblicazione Autore(i) File
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 1-gen-2023 Rainone P.; Valtorta S.; Villa C.; Todde S.; Cadamuro M.; Bertoli G.; Conconi D.; Lavitrano M.; Moresco R.M.
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approac 1-gen-2022 Iannone M.N.; Stucchi S.; Turolla E.A.; Beretta C.; Ciceri S.; Chinello C.; Pagani L.; Todde S.; Ferraboschi P.
Evaluation of Radiotherapy associated with Temozolomide plus Metformin in a GBM immunocompetent microenvironment 1-gen-2021 Salvatore, D; Valtorta, S; Bertoli, G; Todde, S; Iannone, M; Coliva, A; Toninelli, E; Spinelli, A; Zerbetto, F; Villa, S; Di Muzio, N; Moresco, R
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 1-gen-2021 Valtorta, S; Lo Dico, A; Raccagni, I; Martelli, C; Pieri, V; Rainone, P; Todde, S; Zinnhardt, B; De Bernardi, E; Coliva, A; Politi, Ls; Viel, T; Jacobs, Ah; Galli, R; Ottobrini, L; Vaira, V; Moresco, Rm
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 1-gen-2021 Iannone, Mn; Stucchi, S; Turolla, Ea; Beretta, C; Ciceri, S; Chinello, C; Pagani, L; Todde, S; Ferraboschi, P
The evaluation of [18F]FDG and [18F]FLT radiotracers as potential biomarkers of early treatment outcome in triple negative breast cancer (TNBC) 1-gen-2021 Rainone P.; Valtorta S.; Todde S.; Salvatore R.; Moresco R.M.
Assessing glutamine cancer metabolic remodelling in an animal model using PET imaging 1-gen-2015 Valtorta, Silvia; Gaglio, Daniela; Raccagni, Isabella; Belloli, Sara; DI GRIGOLI, Giuseppe; Mastroianni, Fabrizia; Ripamonti, Marilena; Sanvito, Francesca; Todde, SERGIO CAMILLO; Alberghina, Lilia; Moresco, ROSA MARIA
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 1-gen-2015 Curtarello M.; Zulato E.; Nardo G.; Valtorta S.; Guzzo G.; Rossi E.; Esposito G.; Msaki A.; Pasto A.; Rasola A.; Persano L.; Ciccarese F.; Bertorelle R.; Todde S.; Plebani M.; Schroer H.; Walenta S.; MuellerKlieser W.; Amadori A.; Moresco R.M.; Indraccolo S.
Assessing cancer metabolic remodeling in animal models using PET imaging 1-gen-2013 Raccagni, I; Gaglio, D; Valtorta, S; Belloli, S; Di Grigoli, G; Vanoni, M; Mastroianni, F; Todde, S; Alberghina, L; Moresco, R M
Influence of glycolytic phenotype on anti-angiogenic therapy response in ovarian cancer xenograft models evaluated by PET imaging 1-gen-2013 S. Valtorta; I. Raccagni; M. Curtarello; G. Di Grigoli; G. Nardo; E. Zulato; S. Todde; C. Monterisi; S. Indraccolo; R.M. Moresco
Molecular imaging applied on hypoxia evaluation: comparison of BLI, FLI and PET imaging 1-gen-2013 Lo Dico A; Martelli C; Belloli S.; Valtorta S.; Gianelli U.; Tosi D; Todde S.; Monterisi C; Lucignani G.; Moresco R.M;Ottobrini L.
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies. 1-gen-2010 Matarrese M. ; Bedeschi P. ; Scardaoni R. ; Sudati F. ; Savi A. ; Pepe A. ; Masiello V. ; Todde S. ; Gianolli L. ; Messa C. ; Fazio F.
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. 1-gen-2010 Elsinga P ; Todde S ; Penuelas I ; Meyer G ; Farstad B ; FaivreChauvet A ; Mikolajczak R ; Westera G ; GmeinerStopar T ; Decristoforo C ; Radiopharmacy Committee of the EANM.
Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons 1-gen-2010 Calandrino, R; del Vecchio, A; Parisi, R; Todde, S; De Felice, P; Savi, A; Pepe, A; Mrskova, A
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation. 1-gen-2008 Moresco R.M. ; Lavazza T. ; Belloli S. ; Lecchi M. ; Pezzola A. ; Todde S. ; Matarrese M. ; Carpinelli A. ; Turolla E. ; Zimarino V. ; Popoli P. ; Malgaroli A. ; ;Fazio F.
Synthesis and carbon-11 labeling of (R)- and (S)-thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for positron emission tomography. 1-gen-2007 Filannino M.A. ; Matarrese M. ; Turolla E.A. ; Masiello V. ; Moresco R.M. ; Todde S. ; Verza E. ; Magni F. ; Cattaneo A. ; Bachi A. ; Kienle M.G. ; Fazio F.
[C-11]radiosynthesis of Thionisoxetine, potential radioligand for PET imaging in vivo in the norepinephrine transpoter 1-gen-2006 Filanninino, Ma; Matarrese, S; Turolla, Ea; Masiello, V; Moresco, Rm; Todde, S; Verza, E; Magni, F; Cattaneo, A; Bachi, A; Galli Kienle, M; Fazio, F
Automatic production of copper radioisotopes for routine applications 1-gen-2006 Matarrese, M; Bedeschi, P; Scardaoni, R; Sudati, F; Biagetti, Gl; Vaghi, M; Filannino, A; Bosi, S; Savi, A; Todde, S; Fazio, F
Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time 1-gen-2006 Calandrino, R; del Vecchio, A; Savi, A; Todde, S; Griffoni, V; Brambilla, S; Parisi, R; Simone, G; Fazio, F
Improved synthesis and radiolabeling of [(11)C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 1-gen-2006 Carpinelli, A; Magni, F; Cattaneo, A; Matarrese, M; Turolla, E; Todde, S; Bosso, N; Galli Kienle, M; Fazio, F